These three lesser-known biotech companies are profitable and growing revenue.
These two high-tech bio companies may be too cheap to ignore right now.
The company got a bump from an analyst's upgrade.
September S&P 500 futures (ESU23) are up +0.24%, and September Nasdaq 100 E-Mini futures (NQU23) are up +0.32% this morning as investors looked ahead to the Federal Reserve’s interest rate decision while...
Which of these red-hot biotech stocks is the better buy right now?
Amylyx Pharmaceuticals is the rare young biotech that's profitable. The company earned $0.02 a share in Q1, and analysts expect profitability to grow.
These two biopharma stocks might be poised for a major breakout.
Morning Markets June E-Mini S&P 500 futures (ESM2 3) this morning are up +0.28%, and June Nasdaq 100 E-Mini futures (NQM2 3) are up +0.12%. U.S. stock index futures this morning are moderately higher....
June S&P 500 futures (ESM23) are up +0.44%, and June Nasdaq 100 E-Mini futures (NQM23) are up +0.30% this morning after three major U.S. benchmark indices closed mixed on Thursday as renewed concerns about...
Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) will report its first quarter 2023 financial results on Thursday, May 11, 2023, following the close of the U.S. financial...
